Clinical Trial Update: The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of henagliflozin on glucose fluctuation and immunosenescence in adults with type 2 diabetes mellitus on insulin th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin (henagliflozin)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: RECRUITING